Form 4: Health Catalyst Director Jill Hoggard Green Receives Stock Award

Director Jill Hoggard Green of Health Catalyst, Inc. was granted 27,706 restricted stock units (RSUs) on December 1, 2024, which will vest over three years.

Summary

• Jill Hoggard Green, a director at Health Catalyst, Inc., received 27,706 restricted stock units (RSUs) on December 1, 2024.
• These RSUs were granted under the company's 2019 Stock Option and Incentive Plan.
• Each RSU represents the right to receive one share of Health Catalyst's common stock.
• The RSUs will vest in three installments: 33.33% on December 1, 2025, and the remaining 66.67% in two equal annual installments thereafter.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning director and shareholder interests. There are no negative implications.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Risks

• The value of the RSUs is dependent on the future performance of Health Catalyst's stock price.
• The director may not receive the full value of the RSUs if they leave the company before the vesting dates.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service with the company.

Industry Context

Stock-based compensation is a common practice for directors and executives in publicly traded companies to align their interests with shareholders and incentivize long-term performance.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) for director compensation is a standard practice in the technology and healthcare industries.
• Companies like Cerner (now Oracle Health) and Allscripts also use similar equity-based compensation plans for their directors.
• The vesting schedule of three years is also typical, aligning with long-term strategic goals.

Stakeholder Impact

• The RSU grant has a positive impact on shareholders by aligning the director's interests with the company's long-term success.
• The grant does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

restricted stock units, RSUs, stock award, director compensation, Health Catalyst, equity, vesting